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Abstract
Introduction: Randomised controlled trials (RCTs) that fail to meet their recruitment target risk increasing research
waste. Acute stroke RCTs experience notable recruitment issues. The efficiency of recruitment to stroke
rehabilitation RCTs has not been explored.
Aims and objectives: To explore recruitment efficiency and the trial features associated with efficient recruitment
to stroke rehabilitation RCTs.
Methods: A systematic review of stroke rehabilitation RCTs published between 2005 and 2015 identified in a search
of the Cochrane Stroke Group (CSG) Trials Register from 35 electronic databases (e.g. Medline, CINAHL; EMBASE),
clinical trial registers, and hand-searching. Inclusion criteria are stroke rehabilitation intervention, delivered by a
member of the rehabilitation team, and clinically relevant environment. We extracted data on recruitment efficiency
and trial features.
Results: We screened 12,939 titles, 1270 abstracts and 788 full texts, before extracting data from 512 included RCTs
(n = 28,804 stroke survivor participants). This is the largest systematic review of recruitment to date. A third of stroke
survivors screened consented to participate (median 34% (IQR 14–61), on average sites recruited 1.5 participants per
site per month (IQR 0.71–3.22), and one in twenty (6% (IQR 0–13) dropped out during the RCT. Almost half (48%) of
those screened in the community were recruited compared to hospital settings (27%). Similarly, almost half (47%)
those screened at least 6 months after stroke participated, compared to 23% of stroke survivors screened within a
month of stroke. When one recruiter screened multiple sites, a median of one stroke survivor was recruited every 2
months compared to more than two per month when there was a dedicated recruiter per site. RCT recruitment
was significantly faster per site, with fewer dropouts, for trials conducted in Asia (almost three stroke survivors
monthly; 2% dropout) compared to European trials (approximately one stroke survivor monthly; 7% dropout).
Conclusions: One third of stroke survivors screened were randomised to rehabilitation RCTs at a rate of between
one and two per month, per site. One in twenty did not complete the trial. Our findings will inform recruitment
plans of future stroke rehabilitation RCTs. Limited reporting of recruitment details restricted the subgroup analysis
performed.
Trial registration: Prospective Register of Systematic Reviews, registration number CRD42016033067.
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Background
An estimated £132 billion of research funding is
wasted each year [1] and recruitment issues are
thought to be one of the key contributors to research
waste [2]. Successfully meeting recruitment targets is
vital to ensure statistically significant results are cor-
rectly identified (protect against type 1 and type 2 er-
rors) [3–5] and to ensure accurate interpretation of
statistical effect sizes (how effective an intervention
has been) [6–9]. Randomised controlled trials (RCTs)
experience a range of recruitment inefficiencies, in-
cluding falling to achieve recruitment targets, exceed-
ing the planned timeframe, requiring recruitment
extensions, and early termination [3, 5, 10–14]. Be-
tween 1994 and 2002 less than one-third of UK trials
funded by Health Technology Assessment (HTA) or
Medical Research Council (MRC) met their recruit-
ment targets [10]. In an update, just over half the tri-
als published between 2002 and 2008 met recruitment
targets, though the majority recruited at least 80% of
their original target [15]. Trials that fail to retain
their desired sample throughout the duration of the
study also contribute to research waste [16, 17],
impacting on the validity, reliability, and generalisabil-
ity of results [7, 18–20].
RCT reports may lack important recruitment details
[21–23] which hinders learning from past recruitment
experiences amongst similar trial populations or recruit-
ment contexts. Consolidated Standards of Reporting Tri-
als (CONSORT) provides a checklist for reporting
standards and a flow diagram to illustrate the movement
of participants through an RCT [21, 22]. Despite this, a
review of six major journals found that, although 79% of
the included trials reported a CONSORT flow diagram,
one-third of these were incomplete and 40% did not in-
clude the numbers screened for trial eligibility [22].
Recruitment of stroke survivors to clinical trials is
challenging [13, 14, 24]. In the UK more than 100,000
people experience a stroke each year [25, 26] and there
are currently 1.2 million people living with stroke-
related impairments [27–29]. Stroke rehabilitation aims
to maximise recovery, enabling stroke survivors to regain
their confidence, independence, and quality of life [30].
In order to ensure stroke survivors receive the best treat-
ment available, RCTs assess the effectiveness of rehabili-
tation interventions [31]. A systematic review and meta-
analysis of 114 large scale (> 300 participants) acute
(within 1 month after stroke) pharmacological stroke tri-
als published between 1990 and 2004 reported a mean
recruitment rate of 0.79 participants per site per month
[13]. An update of this study revealed a median recruit-
ment rate of 0.41 participants per site per month for tri-
als published between 2010 and 2014 [24]. Despite
notable difficulties recruiting stroke survivors, and
limited improvement over the past 27 years [13, 14], lit-
tle research has focused on recruitment of stroke survi-
vors to rehabilitation RCTs.
A recent James Lind Alliance priority setting partner-
ship looking at priorities for recruitment research
highlighted that improving future recruitment predic-
tions is a key priority [32]. The lack of a recruitment evi-
dence base leads trialists to rely on past experience
when anticipating or forecasting recruitment to their
new RCTs [33]. Trialists tend to base their predictions
on studies with positive recruitment experiences rather
than trials that experienced recruitment challenges [34].
A recruitment evidence base would reduce trialists’ reli-
ance on past experiences when planning future stroke
rehabilitation RCTs [33].
Aims and objectives
The aim of our study was to examine recruitment to
stroke rehabilitation RCTs published from 2005 to 2015.
Specifically, we explored the recruitment efficiency of
the RCTs, determined whether specific trial features im-
pacted upon recruitment efficiency, and explored the
reporting standards of the included RCTs.
Methods
Protocol registration and ethics
Our systematic review protocol was registered with the
international Prospective Register of Systematic Reviews
(CRD42016033067). No ethical approval was required.
Data extracted were securely stored on a password-
protected computer and was fully anonymised at the
point of data extraction. This systematic review was de-
signed in accordance with the Preferred Reporting Items
and Systematic Reviews and Meta-Analysis (PRISMA)
reporting guidelines where applicable.
Inclusion criteria
 Published RCTs (described as RCTs in the paper)
that compared a rehabilitation intervention with a
control condition (usual care, active control, or an
attention control) or another treatment
 Interventions delivered by multi-disciplinary stroke
team members (physiotherapist, occupational ther-
apist, speech and language therapist, physician,
nurse, or psychologist)
 Participants were stroke survivors (including the
control group)
 Interventions were delivered in a stroke
rehabilitation location (hospital, outpatient clinic,
rehabilitation ward, home, community, nursing
home, or support group)
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Identification of studies
We manually hand searched the entire Cochrane Stroke
Group (CSG) specialised trials register. We systematically
searched for all RCTs published between January 2005 and
December 2015. We applied no language restrictions. The
CSG trials register contains trials identified from 37 major
electronic databases (including MEDLINE, EMBASE,
CINAHL, EBSCO, AMED, EMBASE classic, PUBMED,
PSYCBITE, PSYCHINFO, and CENTRAL). The register also
contains more than 25 clinical trial registers and hand
searches of approximately 300 stroke-specific conferences,
150 neurology conferences, 40 neurosurgery conferences,
220 rehabilitation conferences, 60 geriatric conferences, and
96 books. The search strategy used by CSG for MEDLINE
has been provided as an example (Additional file 1: Supple-
ment A). For complete details of the search strategies see
http://www.dcn.ed.ac.uk/csrg/entity/searchmethods.pdf.
Outcomes
Recruitment efficiency was the primary outcome and
measured in terms of the:
1) Randomisation rate (the number of participants
randomised as a percentage of the total number of
participants screened for eligibility)
2) Recruitment rate (number of participants
randomized by the time spent recruiting in months
by site)
3) Dropout (the number of participants that failed to
complete the trial as a percentage of the number
randomised)
Adherence to the CONSORT reporting standards [35]
were evaluated in relation to each trial’s report of the
number of participants randomised, location and set-
tings, baseline demographics, dropouts, the period of re-
cruitment and follow-up, source of funding, and sample
size calculations. A three-tier system was used to classify
the reporting (fully reported, partially reported, and not
reported).
Selection of studies, data extraction and management
All abstracts and full texts were independently screened for
eligibility by two reviewers (KMcG and JMcG). Using a
pro-forma developed and piloted for this review, data ex-
traction was carried out independently, with reference to
the full text and in correspondence with the trialists where
possible. Discrepancies were discussed and resolved, with
discussion with a third reviewer where required. CON-
SORT items relating to recruitment were extracted and
categorised as “reported”, “partially reported” or “not re-
ported”. Where data extraction items were unavailable from
the published article, trialists were contacted via email.
Where a reply was not received within 3 weeks, the original
email was resent (Additional file 1: Supplement B) . All data
were transferred to SPSS for analysis. We extracted data on
trial features (Table 1) and relevant CONSORT items
(Table 2).
Included studies were described in the publications as
RCTs. No evaluation of the quality of the randomisation
process or other standard risk of bias assessments were
undertaken since the purpose of this study was not to
consider the effectiveness of a specific intervention [11,
14, 15, 24, 36–39]. Instead, our systematic review
adopted an inclusive approach to the RCTs identified
allowing a comprehensive evaluation of recruitment to
stroke rehabilitation RCTs.
Data analysis plan
Randomisation rate, recruitment rate and dropout
were stratified into trial and recruitment characteris-
tics to allow for subgroup analysis using Kruskal–
Wallis tests [40]. Where appropriate, Mann–Whitney
U tests were used for post hoc analysis in order to
explore the significant effect highlighted by the Krus-
kal–Wallis tests. Trial and recruitment characteristics
were only used for subgroup analysis if group sizes
were considered balanced [7, 40, 41]. Basic power cal-
culations were referred to, to determine appropriate
subgroup analysis (comparing two groups each of N
subjects leads to the requirement N > [4/“effect”]2 for
the detection of a difference at p = 0.05 and 80%
power, where “effect” is in standard deviations [42]).
Bonferroni corrections were manually applied to all
post hoc analyses (providing corrected alpha values)
in order to control for the effect of multiple compari-
son testing [43]. The accepted alpha value (0.05) was
divided by the number of comparison groups. CON-
SORT reporting items were evaluated using descrip-
tive statistics and displayed within a table and line
graph.
Distribution of data
Kolmogorov–Smirnov (K-S) analysis was used to statisti-
cally test the outcome variables against a normally dis-
tributed bell curve [44]. The K-S highlighted non-
normative distribution for all three dependent variables
(< 0.001). We used non-parametric Kruskal–Wallis tests.
Recruitment and trial characteristics were analysed in in-
dependent groups, typically with three or more variables.
Three of the trial features (publication date, ethics ap-
proval, and type of intervention) had two grouping levels
and therefore non-parametric Mann–Whitney U tests
were adopted.
Results
Of 12,939 titles identified (Fig. 1), 1270 abstracts and
788 full texts were reviewed. We extracted data from
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512 stroke rehabilitation RCTs reflecting the randomisa-
tion of 28,804 stroke survivors. A range of trial characteris-
tics (Table 1) were used for the all subsequent analyses. A
number of trial features were excluded from subgroup ana-
lysis because of insufficient data and imbalances across the
groups (Table 3), leading to highly uneven group sizes
which risked the production of misleading results [40, 41].
Recruitment efficiency
The median randomisation rate for stroke rehabilitation trials
was 34% (RCTs 321, IQR 47%, range 2% to 100%). The me-
dian recruitment rate was 1.5 participants per site per month
(RCTs 242, IQR 2.51, range 0.08 to 40). The median dropout
rate was 6% (RCTs 414, IQR 13%, range 0% to 83%) Table 4.
Randomisation rate was significantly affected by stroke
survivors’ living context, their stage of rehabilitation, the
trial’s recruitment strategy, and the number of trial re-
cruiters (Table 5). Post hoc analyses were performed for
each of the significant effects. Mann–Whitney U tests in-
dicated that recruitment from the community had a sig-
nificantly higher randomisation rate (Mdn = 0.48) than
recruitment from a rehabilitation or stroke-specific envir-
onment (Mdn = 0.27; U = 4210.50; p = 0.003). Screening
community-dwelling stroke survivors had a significantly
higher randomisation rate (Mdn = 0.49) than screening
admissions (Mdn = 0.22; U = 725; p = 0.001). There was a
significant difference between recruitment during acute
(Mdn = 0.23) and chronic stages after stroke (Mdn = 0.47;
U = 2723.5; p = 0.001). No other post hoc comparisons
were significant. The trial features that did not have a sig-
nificant effect on recruitment efficiency were RCT publi-
cation date, trial size, type of intervention, funding
support, ethical approval, target impairment, control con-
dition, recruiter’s profession(s), number of recruiters per
site and continent of recruitment (Additional file 1: Sup-
plement C).
Table 1 Recruitment and trial characteristics extracted from included stroke rehabilitation RCTs
Item extracted Justification
Recruitment characteristics Number of patients screened for
trial participation
Used to generate randomisation rate outcome
Number of patients randomised
into the trial
Used to generate randomisation rate, recruitment rate and dropout outcomes
Number of patients who drop out Used to generate dropout outcome
Number of sites used for recruitment Used to generate recruitment rate outcome
Continent of recruitment Recruitment has been shown to differ between countries [1, 2]
Recruitment strategy The recruitment strategies/methods adopted by trials may affect recruitment
efficiency [3]
Profession of the recruiter The profession of the recruiter may play a role in willingness of patients to
take part in trials [2, 4]. Some professions have been described as ‘gatekeeping’
during the recruitment process [5]
Number of recruiters per site The number of people responsible for recruitment may reduce recruitment
efficiency [6–9]
Trial characteristics Publication date There is evidence to suggest recruitment of stroke survivors for clinical trials
is becoming less efficient [10, 11]




Stroke survivor residence Recruitment from a community setting may lead to more efficient recruitment
to RCTs [11]. Recruitment of acute stroke survivors within a hospital setting has
been highlighted as a problematic recruitment area [10, 11]Stage of rehabilitation
Funding support There are potential issues of bias when certain funding bodies are used [14].
Trialists may be influenced by institution pressures to secure funding [15]
Ethics approval Trialists are concerned by the impact of research governance on the
recruitment process [15, 16]
Table 2 CONSORT checklist recruitment data items for RCTs
CONSORT diagram Inclusion and exclusion criteria Who enrolled participants
Numbers randomised Dropouts Source of funding
Location and settings Data defining the period of recruitment and follow up Sample size calculations
Baseline demographics
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Recruitment rate was significantly affected by trial size,
targeted impairment, continent of recruitment, and re-
cruiters per site (Table 6). Post hoc analyses were per-
formed to further explore potential effects. Mann–
Whitney U tests indicated a significantly slower recruit-
ment rate for the trials with 21 or less participants
(Mdn = 0.83) when compared to 35–60 (Mdn = 2.45;
U = 940.5; p < 0.001). There was a significantly faster re-
cruitment rate within RCTs based in Asia (Mdn = 2.68)
compared to European RCTs (Mdn = 1.28; U = 1969; p >
0.001) and North American RCTs (Mdn = 1.35; U =
706.5; p < 0.001). RCTs conducted in Asia recruited at
least one more patient per site per month than either
European or North American RCTs.
Recruitment rate was significantly slower when re-
cruiters had more than one site (or were not full-time at
the site; Mdn = 0.54) when compared to one recruiter
per site (Mdn = 2.14; U = 152.5; p = 0.001), when com-
pared to between one and two recruiters per site (Mdn =
1.5; U = 174.5; p = 0.008), or when compared to more
than two recruiters per site (Mdn = 1.94; U = 104.5; p <
0.001). There was a significantly faster recruitment rate
for interventions targeting gains in overall disability
(Mdn = 2.16) compared to trials which targeted improve-
ments in arm function (Mdn = 1.34; U = 2071; p = 0.001),
cognition or vision (Mdn = 0.95; U = 764.5; p = 0.006).
There was also a significantly faster recruitment rate for
interventions targeting leg function (Mdn = 1.84) when
compared to trials that targeted gains in arm function
(Mdn = 1.34; U = 1728; p = 0.01), cognition or vision
(Mdn = 2.16; U = 635; p = 0.006). No other significant
comparisons were indicated. The trial features that did
not have a significant effect were publication date, living
context, type of intervention, funding support, ethical
approval, stage of stroke rehab, control condition, re-
cruitment strategy, and recruiters per site (Additional
file 1: Supplement C).
Dropout rate was significantly affected by publication
date, trial size, continent of recruitment, and recruitment
strategy (Table 7). Post hoc analysis was then used to
Fig. 1 PRISMA diagram showing the flow of systematic identification, screening, inclusion and exclusions of records identified
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further explore effects. Mann–Whitney U test indicated
a significantly higher dropout rate for RCTs published in
or after 2010 (Mdn = 0.09) when compared to RCTs
Table 3 Trial and recruitment characteristics for the included
512 stroke rehabilitation RCTs
Trial characteristic categories Number of RCTs in this
category (percentage
of total, n = 512)
Publication date 2009 and before 250 (49%)
2010 and after 262 (51%)
Trial size 21 or fewer participants 128 (25%)
22–34 participants 134 (26%)
35–60 participants 121 (24%)
61–99 participants 66 (13%)
100 or more participants 63 (12%)








Type of intervention Using a technological






















Targeted impairment Arm function 169 (33%)
Leg function 94 (18%)
Overall disability 137 (27%)
Cognitive or vision 61 (12%)
Unreported 51 (10%)
Stage of rehabilitation Acute (0–1 month) 82 (16%)
Acute–subacute 43 (8%)
Subacute (1–6 months) 62 (12%)
Subacute–chronic 37 (7%)
Chronic (> 6 months) 193 (38%)
Any stagea 13 (3%)
Unreported 82 (16%)
Control condition Inactive control (form
of control that lasts
for the same duration
as the intervention but
55 (11%)
Table 3 Trial and recruitment characteristics for the included
512 stroke rehabilitation RCTs (Continued)
Trial characteristic categories Number of RCTs in this
category (percentage
of total, n = 512)
does not have a known
effect [17])
Active control (typically a
comparison intervention
which is known to have








Continent of recruitment Europe 176 (34%)
Asia 137 (27%)





Recruitment strategy Screening admissions 100 (20%)




Screening dischargea 14 (3%)











Research team member 49 (10%)
Combination of the abovea 20 (4%)
Unreported 307 (60%)
Number of recruiters One 57 (11%)
Two or three 59 (11%)
Four or more 38 (7%)
Unreported 358 (70%)













aRemoved from subgroup analysis due to lack of numerical balance increasing
risk of producing misleading results
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published in 2009 or before (Mdn = 0.03; U = 17,390;
p = 0.001). There was a significantly lower dropout rate
for RCTs with 21 or fewer participants (Mdn = 0) when
compared to RCTs with sample sizes of between 22 to
34 participants (Mdn = 0.07; U = 3532; p = 0.001), be-
tween 35 to 60 participants (Mdn = 0.08; U = 2999; p <
0.001), between 60 to 99 participants (Mdn = 0.08; U =
1554; p < 0.001), and trials with at least 100 participants
(Mdn = 0.008; U = 1350; p < 0.001). RCTs conducted in
Asia reported significantly lower dropout rates (Mdn =
0.02) when compared to RCTs conducted in Europe
(Mdn = 0.07; U = 6694; p = 0.002) or North America
(Mdn = 0.08; U = 3747; p = 0.005). RCTs that screened in-
patients experienced significantly lower dropout rates
(Mdn = 0.03) than trials that screened hospital admissions
(Mdn = 0.09; U = 2788; p = 0.015). The trial features that
were found to have no significant effect included stroke
survivor living context, type of intervention, funding sup-
port, ethical approval, targeted impairment, stage of stroke
rehabilitation, control condition, profession of recruiter, re-
cruiters per site (Additional file 1: Supplement C). All non-
significant post-hoc test results have been provided (Add-
itional file 1: Supplement D).
Consort reporting standards
The CONSORT items related to recruitment (CONSORT
diagram, inclusion and exclusion criteria, who enrolled
participants, numbers randomised, dropouts, source of
funding, location and settings, data defining the period of
recruitment and follow up, sample size calculations, base-
line demographics) that were extracted from the 512
RCTs included in the systematic review are presented
(Table 8 and Fig. 2). The percentage of RCTs fully report-
ing the CONSORT diagram improved from 32% to 81%
between 2005 and 2010. The percentage of trial reports
that did not include a CONSORT diagram fell steadily
from 64% to 11% over the same period (Fig. 2).
Table 4 Trial recruitment details and primary recruitment efficiency outcomes (randomisation rate, recruitment rate and dropout) for
included stroke rehabilitation RCTs
RCTs Median (Mdn) IQR Q1 Q3 Min–max
Trial recruitment details Participants screened 321 126 296 52 348 8–4909
Participants randomised 512 34 38.75 21.25 60 4–1209
Recruitment Duration (months) 305 18 19.5 10 29.5 1–152
Number of recruitment sites 363 1 1 1 2 1–71
Recruitment efficiency Randomisation rate 321 34% 47% 14% 61% 2–100%
Recruitment rate 242 1.5 2.51 0.71 3.22 0.08–40
Dropout 414 6% 13% 0% 13% 0–83%
RCTs number of RCTs contributing to analysis, IQR interquartile range, Q1 first quartile, Q3 third quartile
Table 5 Trial and recruitment characteristics that significantly affected randomisation rate for included stroke rehabilitation RCTs
Trial feature Kruskal–Wallis P RCTs Subgrouping (median)
Randomisation
rate
Trial characteristic Stroke survivor living
context
X2(3) = 10.11 0.018 239 Community (48%)*
General hospital (38%)
Stroke-specific environment (27%)







Recruitment strategy X2(2) = 10.34 0.006 167 Screening stroke survivors in the community (49%)*
Screening admissions (22%)
Screening inpatients (35%)
Number of recruiters X2(2) = 6.06 0.048 133 Single recruiter (29%)
Two or three recruiters (40%)*
Four or more recruiters (21%)
* Best recruitment condition
Kruskal–Wallis = appropriate statistics for Kruskal–Wallis test, p = significance level, RCTs = number of RCTs contributing to this finding, X2 = chi squared test
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Discussion
We explored the recruitment efficiency of stroke re-
habilitation RCTs over a 10-year period. We found that
one-third of stroke survivors screened were randomised
into the trial, between one and two were recruited per site
per month, and one in twenty stroke survivors rando-
mised did not complete the trial. Stroke survivors were re-
cruited most efficiently from i) the community, ii) utilising
two or three recruiters per site and iii) within the chronic
stage of recovery (more than 6months after stroke). The
slowest recruitment rate was experienced by i) the smal-
lest RCTs (less than 21 participants), ii) RCTs conducted
in Europe or North America and iii) RCTs using one re-
cruiter to cover multiple sites. The lowest reported drop-
out was experienced by RCTs i) published before 2009, ii)
conducted in Asia and iii) with the smallest sample sizes
(less than 21 participants).
Our systematic review illustrates that stroke rehabilita-
tion RCTs have intensive randomisation rates and rela-
tively slow recruitment [3–5, 10, 13, 14]. Interestingly, the
recruitment rate we observed for stroke rehabilitation
RCTs was faster than the rate experienced by acute stroke
RCTs [13, 14]. Stroke rehabilitation RCTs may have more
freedom to recruit stroke survivors from across different
contexts because of the multiple locations and environ-
ments in which rehabilitation takes place. Stroke survivors
who are no longer in an acute setting may be more able to
attend and commit to clinical trials. However, although it
may be more efficient to recruit chronic stroke survivors
living at home, stroke rehabilitation improvements are
known to be greatest within the early stages following
stroke onset. Thus, recruitment plans should be balanced
with the trial objectives.
CONSORT reporting standards
Almost all included RCTs reported inclusion and exclu-
sion criteria, numbers randomised, location and setting
of trial, baseline demographics, and dropout. Less than a
fifth reported the staff members involved with enrolment
and less than half reported the recruitment duration. A
priori sample size calculations were reported in less than
a third of included RCTs and one-third of RCTs did not
report their funders. CONSORT diagrams were fully re-
ported by less than half of stroke rehabilitation RCTs,
reflecting an improvement in trial reporting over the
past 10 years [22]. This improvement came after the first
major CONSORT update in 2010 [35] and is likely to re-
flect changes in editorial requirements from journals.
Faster recruitment and less dropout for RCTs conducted
in Asia
RCTs conducted in Asia recruited one more patient per
site per month and experienced 5% less dropout when
compared to RCTs conducted in Europe or America.
Cultural differences may have contributed to this effect,
with participants in Asian countries being motivated
more by societal collectivism when compared to western
individualistic societies [45–48]. Collectivist societies
tend to place importance on social identity and societal
benefit [47]. In comparison, individualistic ideologies
Table 6 Trial and recruitment characteristics that significantly affected recruitment rate for included stroke rehabilitation RCTs
Trial feature Kruskal–Wallis P RCTs Subgrouping (medians)




100 ore more (1.62)
Targeted impairment X2(3) = 14.97 0.002 241 Arm function (1.34)
Leg function (1.84)
Overall disability 2.16)*
Cognitive or vision 0.95)
Recruitment characteristics Continent of recruitment X2(2) = 24.21 0.001 283 Europe (1.28)
Asia (2.68)*
North America (1.35)
Recruiters per site X2(3) = 15.97 0.001 122 One recruiter covering multiple sites (0.54)
One recruiter per site (2.14)*
Between one and two recruiters per site (1.5)
More than two recruiters per site (1.9)
* Best recruitment condition
Kruskal-wallis = appropriate statistics for Kruskal–Wallis test, p = significance level, RCTs = number of RCTs contributing to this finding
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place more importance on self-importance and self-gain
[48]. Stroke survivors based in Asian countries may be
more willing to take part in RCTs because they find
value in the potential societal benefits. Another potential
influencing factor is the difference in medical staff–pa-
tient relationships [49–52]. Southeast Asia tends to have
a more authoritarian approach to this interaction, with
medical staff directing patients with little feedback [49,
53]. Furthermore, recruitment for RCTs conducted in
Asia may be considered unethical by western standards,
potentially affecting recruitment rate by reducing the
need for some safeguards associated with modern re-
search governance [54–57]. Of 9488 Chinese RCTs pub-
lished between 2013 and 2016 across 12 nursing
journals, informed consent was reported in only 51.8%
of RCTs, and written consent in only 27.4%. Potentially,
ethical processes for Asian trials could be improved by
targeted research governance initiatives, leading to more
trials using informed consent.
Recruitment from the community
For stroke rehabilitation RCTs community-based trials ap-
pear to have the most efficient recruitment. During the
chronic stage of recovery stroke survivors may be in a bet-
ter position to be approached regarding trial participation
because the immediate psychological and physical impli-
cations for the stroke survivor have subsided [25, 26] and
the most intensive period of standard rehabilitation is
likely to have been completed [25, 26]. By recruiting
chronic stroke survivors within the community there may
be more time to form relationships and this approach
could increase trust during the recruitment conversation
[58, 59]. Recruitment forecasting should carefully consider
Table 7 Trial and recruitment characteristics that significantly affected dropout for included stroke rehabilitation RCTs
Trial feature Kruskal-Wallis P RCTs Subgrouping (medians)
Dropout Trial characteristic Publication date X2(1) = 10.73 0.001 414 2009 or before (3%)*
2010 or after (9%)




100 ore more (8%)
Recruitment characteristic Continent of recruitment X2(2) = 11.91 0.003 354 Europe (7%)
Asia (2%)
North America (8%)




Kruskal–Wallis = appropriate statistics for Kruskal–Wallis test, p = significance level, RCTs = number of RCTs contributing to this finding
Table 8 Number and percentage of RCTs that included each CONSORT reporting item associated with recruitment
Consort reporting item Data availability Fully reported Poorly reported Not reported
Consort diagram 512 240 (47%) 48 (9%) 224 (44%)
Inclusion and exclusion criteria 459 439 (96%) 4 (1%) 16 (3%)
Who enrolled participants 459 86 (19%) 373 (81%)
Number randomised 459 459 (100%)
Dropout 459 388 (85%) 71 (15%)
Funding 459 319 (69%) 140 (31%)
Location and setting 459 395 (86%) 57 (13%) 6 (1%)
Period spent with recruitment and follow-up 459 194 (42%) 266 (58%)
Sample size calculations 459 129 (28%) 330 (72%)
Baseline demographics 459 435 (95%) 6 (1%) 18 (4%)
%= percentage of 512 included trials
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the location of recruitment and the stage of rehabilitation
when allocating recruitment time.
Recruitment staffing levels
Having one recruiter covering multiple sites who has a
high work load may affect the ability to identify, screen,
and approach potentially eligible participants for recruit-
ment [10]. This is potentially contributed to by under-
resourcing during trial planning [33], affecting the
amount of time the clinical staff have to recruit [60].
However, the evidence did not support the notion that
more recruiters led to more efficient recruitment. This
may be caused by the lack of personal responsibility for
a site’s recruitment target and accountability for recruit-
ment failures. This may be caused by diffusion of re-
sponsibility [61–63] where individuals do not feel
personally responsible for a task owing to the belief that
someone else will do it, and this is effected by how com-
petent an individual feels in their ability to complete a
task [64].
Strengths of our systematic review
We adopted rigorous methods to search, screen, extract,
and analyse all included stroke rehabilitation RCTs. The
comprehensive nature of our search strategy supported
the inclusion of all stroke rehabilitation RCTs published
between 2005 and 2015. Two researchers independently
screened all identified trials to ensure that all decisions
were independently checked. Our systematic review in-
cluded 512 stroke rehabilitation RCTs, making it the lar-
gest systematic review of trial recruitment conducted to
date. Our large sample size ensured that our analysis
had the statistical power to confidently protect against
type 1 and type 2 errors and supported subgroup ana-
lysis of the trial features that could be important for re-
cruitment efficiency. In total, additional information was
provided by 177 authors, substantially increasing the
availability of data for subgroup analysis.
Limitations of the systematic review
RCTs were included if the author described randomization
methods. Inclusion of RCTS without quality appraisal was
intentional in order to include and evaluate stroke rehabili-
tation RCTs regardless of quality. This allowed for the ex-
ploration of recruitment to all stroke rehabilitation RCTs,
creating a well-rounded picture of the body of research.
The ability to include RCTs not published in English could
have contributed to the investigation of more trial features
that impact recruitment efficiency. Unfortunately, the lack
of reporting of recruitment details by RCTs governed some
of the subgroup analysis that could be conducted. Some
trial features that could have provided an insight into what
makes for successful recruitment may have been missed.
We did not extract individual participant level data on
stroke severity (NIHSS for example) as our analysis was
based only on group summary data. It is possible that
stroke profile factors (such as severity of stroke, ability to
consent, communication impairment) are important factors
for trial participation at an individual participant level but
these were not examined in our review.
Implications
The output from this study provides an evidence base
for stroke rehabilitation trialists planning future RCTs.
This evidence base could allow for more efficient re-
cruitment to stroke rehabilitation RCTs through more
accurate recruitment forecasting and knowledge of what
trial features appear to facilitate efficient recruitment.
We hope in future to observe a reduction in a) the num-
ber of trials that do not reach their target sample size, b)
the production of inaccurate and unusable outcomes
and c) the number of costly extensions and trial termi-
nations. Better recruitment to stroke rehabilitation trials
Fig. 2 Reporting, partial reporting and not reporting CONSORT diagram in published reports of stroke rehabilitation RCTs published between
2005 and 2015
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would lead to more accurate assessments of experimen-
tal treatment effects [3–5, 65], contributing to a more
robust evidence base for stroke rehabilitation clinicians
and better rehabilitation for stroke survivors.
Conclusions
Stroke rehabilitation RCTs experience recruitment inef-
ficiencies including intensive screening rates and slow
recruitment. RCTs recruiting stroke survivors living at
home several months after their stroke had the highest
level of recruitment efficiency. One recruiter based at a
single site was the most efficient approach while a single
recruiter covering multiple sites was the least efficient.
Trials conducted in Asia experience significantly faster
recruitment and fewer dropouts. Our findings will assist
recruitment planning of future stroke rehabilitation
RCTs contributing to a reduction in research waste
amongst future stroke rehabilitation trials.
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